glecaprevir
Generic: glecaprevir·Brand: Mavyret
glecaprevir: developed by 1 company.
glecaprevir evidence translation
What we can confirm
No verified FDA or trial count is available.
What it means
Source-backed records connect glecaprevir to ENTA; that link alone does not prove the drug works.
What to watch
Evidence is limited; missing information remains unknown.
BioSniper AIPage evidence connected
Prepared research question
How could glecaprevir → ENTA affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Acute and chronic hepatitis C virus (HCV) infection, genotypes 1–6Drug Interaction
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) Acute and chronic hepatitis C virus (HCV) infection, genotyp… | Approved |
| ENANTA PHARMACEUTICALS INC (ENTA) Drug Interaction | Approved |